The estimated Net Worth of Bruce Mc Gillivray is at least $1.44 millió dollars as of 28 August 2008. Bruce Gillivray owns over 141,910 units of Baxter International stock worth over $1,442,387 and over the last 20 years Bruce sold BAX stock worth over $0.
Bruce has made over 2 trades of the Baxter International stock since 2007, according to the Form 4 filled with the SEC. Most recently Bruce exercised 141,910 units of BAX stock worth $5,244,994 on 28 August 2008.
The largest trade Bruce's ever made was exercising 141,910 units of Baxter International stock on 28 August 2008 worth over $5,244,994. On average, Bruce trades about 12,952 units every 31 days since 2004. As of 28 August 2008 Bruce still owns at least 36,730 units of Baxter International stock.
You can see the complete history of Bruce Gillivray stock trades at the bottom of the page.
Bruce's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney és Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: